Screener/Healthcare/Biotechnology

ORKA

Oruka Therapeutics, Inc.NASDAQ
$39.91-1.56 (-3.75%)
$5.49
$42.88
$39.05
$40.78
EPS (TTM)$-3.01
P/E Ratio
Dividend Yield57.25%
Market Cap$1.27B
Volume321K
Prev Close$41.56
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$30.3M$-0.69
Q2 '25$0-$24.6M$-0.46
Q1 '25$0-$21.0M$-0.40
Q3 '24$0-$28.6M$-1.46
Get Your Daily Market Recap